We are live on ! Find out more
CS

Cannell & Spears Portfolio holdings

AUM $5.1B
1-Year Est. Return 31.77%
This Fund
S&P 500
This Quarter Est. Return
+4.7%
1 Year Est. Return
+31.77%
3 Year Est. Return
+94.5%
5 Year Est. Return
+108.17%
10 Year Est. Return
+357.88%
AUM
$791M
AUM Growth
+$12.6M
Cap. Flow
-$19.3M
Cap. Flow %
-2.44%
Top 10 Hldgs %
45.52%
Holding
139
New
7
Increased
27
Reduced
43
Closed
7

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$11.1M
2
KEY icon
KeyCorp
KEY
+$3.27M
3
UPS icon
United Parcel Service
UPS
+$1.06M
4
SLB icon
SLB Ltd
SLB
+$915K
5
XOM icon
ExxonMobil
XOM
+$579K

Top Sells

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$9.74M
2
JPM icon
JPMorgan Chase
JPM
+$9.72M
3
MET icon
MetLife
MET
+$6.47M
4
CB icon
Chubb
CB
+$4.94M
5
CVS icon
CVS Health
CVS
+$849K

Sector Composition

Rank Sector Weight
1 Financials 25.6%
2 Healthcare 19.03%
3 Technology 16.01%
4 Industrials 13.19%
5 Consumer Discretionary 9.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPGI icon
126
S&P Global
SPGI
$133B
$209K 0.03%
+1,600
New +$199K
BMY icon
127
Bristol-Myers Squibb
BMY
$124B
$203K 0.03%
3,730
PX
128
DELISTED
Praxair Inc
PX
$201K 0.03%
1,696
-95
-5% -$11.2K
ENDP
129
DELISTED
Endo International plc
ENDP
$188K 0.02%
16,831
NYT icon
130
New York Times
NYT
$12.3B
$184K 0.02%
12,786
WEN icon
131
Wendy's
WEN
$1.48B
$140K 0.02%
10,267
WFT
132
DELISTED
Weatherford International plc
WFT
$70K 0.01%
10,575
KMB icon
133
Kimberly-Clark
KMB
$36B
-5,295
Closed -$604K
NKE icon
134
Nike
NKE
$64.9B
-11,597
Closed -$589K
SNY icon
135
Sanofi
SNY
$107B
-12,204
Closed -$494K
TIP icon
136
iShares TIPS Bond ETF
TIP
$14.6B
-1,908
Closed -$216K
VIG icon
137
Vanguard Dividend Appreciation ETF
VIG
$111B
-2,352
Closed -$200K
CERN
138
DELISTED
Cerner Corp
CERN
-5,737
Closed -$272K
MJN
139
DELISTED
Mead Johnson Nutrition Company
MJN
-7,832
Closed -$554K

Similar funds

Cannell & Spears's Q1 2017 Portfolio in Review

As of Q1 2017, Cannell & Spears held 139 positions worth $791M, up 1.6% from $779M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Cannell & Spears's Q1 2017 filing shows 7 new, 27 increased, 43 reduced and 7 closed positions. Its largest new stake was KeyCorp: 178,634 shares worth $3.18M. The largest sale was Thermo Fisher Scientific, an estimated $9.74M.

By sector, the portfolio is most concentrated in Financials at 26% of assets, down from 29% a quarter earlier, followed by Healthcare and Technology.

  • Cannell & Spears's largest Q1 2017 buy was KeyCorp: 178,634 shares worth $3.18M.
  • Cannell & Spears added most to Gilead Sciences in Q1 2017, an estimated $11.1M increase.
  • Cannell & Spears's biggest Q1 2017 reduction was Thermo Fisher Scientific, cutting an estimated $9.74M.
  • Cannell & Spears fully exited Kimberly-Clark in Q1 2017, selling an estimated $604K.
  • Cannell & Spears's ten largest holdings make up 46% of its $791M portfolio in Q1 2017.
  • Cannell & Spears opened 7 new positions and closed 7 in Q1 2017.
  • Cannell & Spears's portfolio value rose 1.6% quarter-over-quarter to $791M.

Based on Cannell & Spears's 13F filing for Q1 2017, filed 10 May 2017.